StockClub

TEVA

TEVATeva Pharmaceutical Industries Limited$ --
Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited

TEVA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
3,981M USD
YoY +2.3%
Operating Income
652M USD
YoY +25.6%
Net Income
369M USD
YoY +72.4%
EPS
0.32$
YoY +68.4%

Revenue

$4B
FY2024 Q2$8B
$8B
Q2
FY2024 Q3$12.3B
$12.3B
Q3
FY2024 Q4$16.5B
$16.5B
Q4
FY2025 Q1$3.9B
$3.9B
Q1
FY2025 Q2$8.1B
$8.1B
Q2
FY2025 Q3$12.5B
$12.5B
Q3
FY2025 Q4$17.3B
$17.3B
Q4
FY2026 Q1$4B
$4B
Q1
Actual
+$90M (+2.3%)

Net Income

$369M
FY2024 Q2$-985M
$-985M
Q2
FY2024 Q3$-1.4B
$-1.4B
Q3
FY2024 Q4$-1.6B
$-1.6B
Q4
FY2025 Q1$214M
$214M
Q1
FY2025 Q2$496M
$496M
Q2
FY2025 Q3$929M
$929M
Q3
FY2025 Q4$1.4B
$1.4B
Q4
FY2026 Q1$369M
$369M
Q1
Actual
+$155M (+72.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$16.7B
Est:$16.6B
FY2020BEAT
$16.7B
FY2021MISS
Actual:$15.9B
Est:$16.1B
FY2021MISS
$15.9B
FY2022MISS
Actual:$14.9B
Est:$15B
FY2022MISS
$14.9B
FY2023MISS
Actual:$15.8B
Est:$16.3B
FY2023MISS
$15.8B
FY2024BEAT
Actual:$16.5B
Est:$16.4B
FY2024BEAT
$16.5B
FY2025BEAT
Actual:$17.3B
Est:$16.9B
FY2025BEAT
$17.3B

Analyst Estimates